Matthijs A. Velders

Second-Generation Everolimus-Eluting Stents Versus First-Generation Sirolimus-Eluting Stents in Acute Myocardial Infarction

Sjoerd H. Hofma, Jan Brouwer, Matthijs A. Velders et al. · Journal of the American College of Cardiology · 2012 · 127 citations

Percutaneous Coronary Intervention, Cardiovascular Disease, Second-generation Everolimus-eluting Stents +9

Outcome After ST Elevation Myocardial Infarction in Patients With Cancer Treated With Primary Percutaneous Coronary Intervention

Matthijs A. Velders, Helèn Boden, Sjoerd H. Hofma et al. · The American Journal of Cardiology · 2013 · 120 citations

Percutaneous Coronary Intervention, Cardiovascular Disease, Medicine +8

Intramyocardial Injection of Autologous Bone Marrow-Derived Ex Vivo Expanded Mesenchymal Stem Cells in Acute Myocardial Infarction Patients is Feasible and Safe up to 5 Years of Follow-up

Sander F. Rodrigo, Jan van Ramshorst, Georgette E. Hoogslag et al. · Journal of Cardiovascular Translational Research · 2013 · 105 citations · Full text

Tissue Engineering, Cell Therapy, Heart Failure +21

Prognosis of elderly patients with ST-elevation myocardial infarction treated with primary percutaneous coronary intervention in 2001 to 2011: A report from the Swedish Coronary Angiography and Angioplasty Registry (SCAAR) registry

Matthijs A. Velders, Stefan James, Berglind Libungan et al. · American Heart Journal · 2014 · 73 citations

Percutaneous Coronary Intervention, Cardiovascular Disease, Elderly Patients +12

Safety and efficacy of ticagrelor and clopidogrel in primary percutaneous coronary intervention

Matthijs A. Velders, Jérémie Abtan, Dominick J. Angiolillo et al. · Heart · 2016 · 65 citations